Diclofenac / misoprostol Delayed Release Oral Tablet
RxNorm 1808539
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1808539 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: diclofenac / misoprostol Delayed Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDFPrescribable
Semantic Clinical Drug Form (SCDF):
Diclofenac / misoprostol Delayed Release Oral Tablet
(Atom ID: 12263263)
TMSYPrescribable
Tall Man Lettering Synonym (TMSY):
Diclofenac / miSOPROStol Delayed Release Oral Tablet
(Atom ID: 12430601)
Patient Education
Diclofenac and Misoprostol
The combination of diclofenac and misoprostol is used to relieve the pain, tenderness, swelling, and stiffness caused by osteoarthritis (arthritis caused by a breakdown of the lining of the joints) and rheumatoid arthritis (arthritis caused by swelling of the lining of the joints) in patients who have a high risk of developing stomach ulcers. Diclofenac is in a class of medications called NSAIDs. It works by stopping the body's production of a substance that causes pain and inflammation. Misoprostol is in a class of medications called prostaglandins. It prevents ulcers caused by diclofenac by protecting the stomach lining and decreasing stomach acid production.
[Learn More]
* Please review the disclaimer below.